FDA releases GDUFA II fee for FY20; Teva to recover settlement charge from execs
This week, the USFDA released its GDUFA II user fee for fiscal 2020.
Unlike last year, when the fees were hiked significantly...
Impressions : 1685
Apotex blamed for FDA rejection of Biohaven`s new drug; Canada opposes Trump’s plan to import drugs
This week, Phispers brings you news about another setback to the Trump administration’s efforts at tackling high drug pri...
Impressions : 2924
- Privacy policy
- Terms and conditions
- Disclaimers
-
- Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.